March 15/Columbia, Md./Press Release -- Advanced BioNutrition Corp. (ABN) announced the signing of a technology agreement with Chr. Hansen A/S. The technology agreement focuses on adapting ABN’s patented technologies to stabilize probiotics in defined applications, and as research shows, may be beneficial in a wide variety of intestinal disorders.

This is the first technology agreement Advanced BioNutrition has signed with a food nutrients company. Terms of the agreement were not disclosed.

“We are pleased to have this opportunity to work with Chr. Hansen,” said Larry Loehr, director of ABN Business Development. “We look forward to a successful completion of this technology agreement with Chr. Hansen and additional work with this great company.”

“Chr. Hansen is a global supplier of bioscience-based ingredients to the food, health and animal feed industries, said Lasse Nagell, vice president, Sales & Marketing Human Health & Nutrition Division, for Chr. Hansen. “We produce cultures and dairy enzymes, probiotics and natural colors. Our business is built on our product innovation and applications, production processes, long-term customer relationships and intellectual property. We believe ABN’s technologies will help us stabilize and deliver probiotics and other nutrients in a number of applications.

 From the March 16, 2012, Prepared Foods' Daily News.